Stereotactic radiosurgery, chemotherapy regimen failed to improve OS in brain metastases among NSCLC patients

  • June 18, 2014

CHICAGO — Grace Dy, MD, associate professor in the department of medicine at Roswell Park Cancer Institute, discusses the results of a randomized phase 3 trial of stereotactic radiosurgery vs. observation for patients with asymptomatic cerebral oligo-metastases in non-small cell lung cancer.